Jackson Creek Investment Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Sell
36,484
-13,830
-27% -$580K 0.56% 33
2026
Q1
$1.62M Sell
50,314
-833
-2% -$30.8K 0.48% 94
2025
Q4
$2.15M Sell
51,147
-2,251
-4% -$90.7K 0.64% 21
2025
Q3
$1.83M Sell
53,398
-21
-0% -$602 0.53% 69
2025
Q2
$1.44M Buy
53,419
+6,351
+13% +$184K 0.39% 137
2025
Q1
$1.4M Sell
47,068
-27
-0.1% -$1.03K 0.44% 100
2024
Q4
$1.86M Sell
47,095
-1,456
-3% -$55.1K 0.56% 23
2024
Q3
$1.65M Buy
+48,551
New +$1.37M 0.49% 67
2024
Q1
Sell
-37,617
Closed -$1.03M 372
2023
Q4
$1.03M Sell
37,617
-18
-0% -$435 0.4% 97
2023
Q3
$840K Buy
+37,635
New +$968K 0.35% 147
2021
Q4
Sell
-24,659
Closed -$1.15M 357
2021
Q3
$1.15M Buy
+24,659
New +$1.08M 0.43% 73
2021
Q2
Sell
-17,171
Closed -$923K 360
2021
Q1
$923K Sell
17,171
-510
-3% -$29.4K 0.32% 173
2020
Q4
$865K Buy
+17,681
New +$819K 0.34% 167

Other funds holding VCYT

Jackson Creek Investment Advisors's VCYT Position: Q2 2026 in Review

Jackson Creek Investment Advisors reduced its Veracyte (VCYT) stake by 27% in Q2 2026, selling an estimated $580K and leaving 36,484 shares worth $1.69M. The position accounts for 0.56% of the portfolio, ranked #33.

Jackson Creek Investment Advisors first reported a position in VCYT in Q4 2020 and has held it in 13 quarters since. The position peaked at $2.15M in Q4 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Jackson Creek Investment Advisors held 36,484 shares of Veracyte worth $1.69M as of Q2 2026.
  • Jackson Creek Investment Advisors sold 13,830 Veracyte shares in Q2 2026, an estimated $580K.
  • Veracyte made up 0.56% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #33 holding.
  • Jackson Creek Investment Advisors first reported a position in Veracyte in Q4 2020 and has held it in 13 quarters since.
  • Jackson Creek Investment Advisors's Veracyte position peaked at $2.15M in Q4 2025.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.